The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Carboplatin and paclitaxel chemoradiation for localized anal cancer in patients not eligible for mitomycin and 5-fluorouracil.
 
Alyssa DeZeeuw
No Relationships to Disclose
 
Patrick Thomas Grogan
No Relationships to Disclose
 
Kayla Lemmon
No Relationships to Disclose
 
Jenna Wilke
No Relationships to Disclose
 
Anica Bausch
No Relationships to Disclose
 
Jeremy D. Kratz
Research Funding - BMS; Boehringer Ingelheim
 
Noelle K. LoConte
Consulting or Advisory Role - Abbvie; Abbvie; Personal Genome Diagnostics
Research Funding - Exact Sciences
 
Sam Joseph Lubner
Stock and Other Ownership Interests - Elephas Bio
Consulting or Advisory Role - Elephas Bio
Research Funding - Agios (Inst); AstraZeneca/MedImmune/Spirogen (Inst); Bristol Myers Squibb Foundation (Inst); Incyte (Inst)
 
Nataliya Volodymyrivna Uboha
Stock and Other Ownership Interests - Exact Sciences (I); Natera (I)
Consulting or Advisory Role - Aptitude Health; Astellas Pharma; Astellas Pharma; AstraZeneca; BostonGene; Bristol Myers Squibb Foundation; Bristol-Myers Squibb/Roche; Eisai/MSD; Elevation Oncology; GRAIL; Helsinn Therapeutics; Ipsen; ipsen; Pfizer
Research Funding - EMD Serono (Inst); ipsen (Inst)
 
Monica Arun Patel
Honoraria - OncLive/MJH Life Sciences
 
Michael F. Bassetti
No Relationships to Disclose
 
Dustin A. Deming
Consulting or Advisory Role - Bayer; Lilly; Pfizer; Seagen
Research Funding - AADi (Inst); Arcus Ventures (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Curegenix (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Natera (Inst); Promega (Inst); Revolution Medicines (Inst); Strata Oncology (Inst)